{"version":"1.0","type":"link","title":"Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial.","author_name":"Sehgal K 외","author_url":"https://prs-insight.online/author/Sehgal%20K","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/142344","thumbnail_width":1200,"thumbnail_height":630}